论文部分内容阅读
由于不同的癌种性质各异,故仅用单一作用机制的药物实不能满足临床需求。这也从一个方面说明了抗肿瘤药物开发的难度。本文欲就目前抗肿瘤药物的现状及开发方向、研究进展、存在的问题等作一简要介绍。一、最大的研究课量之一长期以来,被称之为“不治之症”的肿瘤一直是医药界最大的研究课题之一,但基础研究的进步却未直接推动其药物开发水平的提高。已有的抗肿瘤药物效果都有限,且副作用严重,离人们所期待出现的“特效药”相距甚远。
Due to the different nature of the cancer, so only a single mechanism of action of the drug can not meet the clinical needs. This also illustrates the difficulty of antitumor drug development from one aspect. This article wants to make a brief introduction of the current status and development direction of anticancer drugs, research progress, existing problems and so on. One of the largest research curricula For a long time, the tumor known as “incurable disease” has been one of the largest research topics in the pharmaceutical industry. However, advances in basic research have not directly promoted the level of drug development improve. Existing antitumor drugs have limited effects and serious side effects, far away from what people expect to appear.